FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Masahide Fukudo

Research Profile

Chemicals & Drugs

Procedures

Living Beings

Living Donors

Concepts & Ideas

Disorders

Physiology

Graft Rejection

Anatomy

Leukocytes, Mononuclear

Co-author Network

Publications

TOP 3
Yosuke Togashi; Tomoyuki Mizuno; Hiroki Nagai; Yuichi Sakamori; Masahide Fukudo; Yasuaki Ikemi; Toshiya Katsura; Young-Hak Kim; Katsuhiro Masago; Satohiro Masuda; Michiaki Mishima
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer.
Ikuko Yano; Yuko Yoshida; Atsushi Yoshizawa; Hiroto Egawa; Masahide Fukudo; Sachiyo Hashi; Toshimi Kaido; Satohiro Masuda; Akira Mori; Kohei Ogawa; Yasuhiro Ogura; Mitsuhiro Sugimoto; Shinji Uemoto; Ken-Ichi Inui
Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantation.
Tomoyuki Mizuno; Eijiro Nakamura; Osamu Ogawa; Tomohiro Terada; Masahide Fukudo; Ken-Ichi Inui; Tomomi Kamba; Toshiya Katsura
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Masahide Fukudo (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Yosuke Togashi; Tomoyuki Mizuno; Hiroki Nagai; Yuichi Sakamori; Masahide Fukudo; Yasuaki Ikemi; Toshiya Katsura; Young-Hak Kim; Katsuhiro Masago; Satohiro Masuda; Michiaki Mishima
Cerebrospinal fluid concentration of gefitinib and erlotinib in patients with non-small cell lung cancer.
Cancer chemotherapy and pharmacology 2012;70(3):399-405.
2012: Ikuko Yano; Yuko Yoshida; Atsushi Yoshizawa; Hiroto Egawa; Masahide Fukudo; Sachiyo Hashi; Toshimi Kaido; Satohiro Masuda; Akira Mori; Kohei Ogawa; Yasuhiro Ogura; Mitsuhiro Sugimoto; Shinji Uemoto; Ken-Ichi Inui
Significance of trough monitoring for tacrolimus blood concentration and calcineurin activity in adult patients undergoing primary living-donor liver transplantation.
European journal of clinical pharmacology 2012;68(3):259-66.
2012: Tomoyuki Mizuno; Eijiro Nakamura; Osamu Ogawa; Tomohiro Terada; Masahide Fukudo; Ken-Ichi Inui; Tomomi Kamba; Toshiya Katsura
Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.
Drug metabolism and pharmacokinetics 2012;27(6):631-9.
2011: Yosuke Togashi; Yasuhiro Tsuchido; Chiyuki Okuda; Yuichi Sakamori; Masahide Fukudo; Yasuaki Ikemi; Toshiya Katsura; Young-Hak Kim; Katsuhiro Masago; Tadashi Mio; Michiaki Mishima
Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation.
Cancer chemotherapy and pharmacology 2011;68(4):1089-92.
2011: Katsuhiro Masago; Tadashi Mio; Yuichi Sakamori; Tomohiro Terada; Yosuke Togashi; Masahide Fukudo; Ken-Ichi Inui; Kaoru Irisa; Young-Hak Kim; Michiaki Mishima
Plasma and pleural fluid pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small-cell lung cancer with pleural effusion.
Clinical lung cancer 2011;12(5):307-12.
2010: Yosuke Togashi; Katsuhiro Masago; Michiaki Mishima; Masahide Fukudo; Ken-Ichi Inui
A case of radiation recall pneumonitis induced by erlotinib, which can be related to high plasma concentration.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(6):924-5.
2010: T Mizuno; Tomohiro Terada; Tomomi Kamba; Masahide Fukudo; Toshiya Katsura; E Nakamura; O Ogawa; Ken-ichi Inui
ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(6):1382-3.
2010: Yosuke Togashi; Katsuhiro Masago; Masahide Fukudo; Tomohiro Terada; Yasuaki Ikemi; Young-Hak Kim; Shiro Fujita; Kaoru Irisa; Yuichi Sakamori; Tadashi Mio; Ken-Ichi Inui; Michiaki Mishima
Pharmacokinetics of erlotinib and its active metabolite OSI-420 in patients with non-small cell lung cancer and chronic renal failure who are undergoing hemodialysis.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2010;5(5):601-5.
2010: Masahide Fukudo; Ikuko Yano; Toshiya Katsura; Noriyuki Ito; Shingo Yamamoto; Toshiyuki Kamoto; Osamu Ogawa; Ken-Ichi Inui
A transient increase of calcineurin phosphatase activity in living-donor kidney transplant recipients with acute rejection.
Drug metabolism and pharmacokinetics 2010;25(5):411-7.
2009: Masahide Fukudo; Ikuko Yano; Keiko Shinsako; Toshiya Katsura; Yasutsugu Takada; Shinji Uemoto; Ken-Ichi Inui
Prospective evaluation of the bayesian method for individualizing tacrolimus dose early after living-donor liver transplantation.
Journal of clinical pharmacology 2009;49(7):789-97.
2008: Masahide Fukudo; Ikuko Yano; Atsushi Yoshimura; Satohiro Masuda; Miwa Uesugi; Keiko Hosohata; Toshiya Katsura; Yasuhiro Ogura; Fumitaka Oike; Yasutsugu Takada; Shinji Uemoto; Ken-ichi Inui
Impact of MDR1 and CYP3A5 on the oral clearance of tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients.
Pharmacogenetics and genomics 2008;18(5):413-23.
2007: Masahide Fukudo
[Individualized dosage regimen of immunosuppressive drugs based on pharmacokinetic and pharmacodynamic analysis].
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2007;127(7):1081-9.
2006: Masahide Fukudo; Ikuko Yano; Satohiro Masuda; Maki Goto; Miwa Uesugi; Toshiya Katsura; Yasuhiro Ogura; Fumitaka Oike; Yasutsugu Takada; Hiroto Egawa; Shinji Uemoto; Ken-ichi Inui
Population pharmacokinetic and pharmacogenomic analysis of tacrolimus in pediatric living-donor liver transplant recipients.
Clinical pharmacology and therapeutics 2006;80(4):331-45.
2006: Sachio Fukatsu; Masahide Fukudo; Satohiro Masuda; Ikuko Yano; Toshiya Katsura; Yasuhiro Ogura; Fumitaka Oike; Yasutsugu Takada; Ken-ichi Inui
Delayed effect of grapefruit juice on pharmacokinetics and pharmacodynamics of tacrolimus in a living-donor liver transplant recipient.
Drug metabolism and pharmacokinetics 2006;21(2):122-5.
2006: Masahide Fukudo; Ikuko Yano; Satohiro Masuda; Toshiya Katsura; Yasuhiro Ogura; Fumitaka Oike; Yasutsugu Takada; Koichi Tanaka; Ken-Ichi Inui
Cyclosporine exposure and calcineurin phosphatase activity in living-donor liver transplant patients: twice daily vs. once daily dosing.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2006;12(2):292-300.
2005: Masahide Fukudo; Ikuko Yano; Satohiro Masuda; Sachio Fukatsu; Toshiya Katsura; Yasuhiro Ogura; Fumitaka Oike; Yasutsugu Takada; Koichi Tanaka; Ken-ichi Inui
Pharmacodynamic analysis of tacrolimus and cyclosporine in living-donor liver transplant patients.
Clinical pharmacology and therapeutics 2005;78(2):168-81.
2005: Masahide Fukudo; Ikuko Yano; Satohiro Masuda; Masahiro Okuda; Ken-Ichi Inui
Distinct inhibitory effects of tacrolimus and cyclosporin a on calcineurin phosphatase activity.
The Journal of pharmacology and experimental therapeutics 2005;312(2):816-25.
2003: Masahide Fukudo; Ikuko Yano; Sachio Fukatsu; Hideyuki Saito; Shinji Uemoto; Tetsuya Kiuchi; Koichi Tanaka; Ken-ichi Inui
Forecasting of blood tacrolimus concentrations based on the Bayesian method in adult patients receiving living-donor liver transplantation.
Clinical pharmacokinetics 2003;42(13):1161-78.